The ADC market: Hot – or too hot to handle?

Published on May 3, 2024

Antibody-drug conjugates (ADCs) are a unique class of drug compound, comprising a monoclonal antibody (mAb), a linker, and a cytotoxic payload. Together, these make it possible to target tumors with far greater specificity than with traditional forms of treatment. “This unique design enables ADCs to achieve ‘targeted chemotherapy’ and provides advantages over conventional chemotherapy and […]

Continue reading on website
Other news

Tikis & Titres: Facility Tour & Luau Dinner Event at BIO

May 2, 2024
Join us on Tuesday, June 4th for a special facility tour and luau dinner event during BIO in San Diego, CA entitled “Tikis & Titres”.Come join us for an evening filled with science and excitement during BIO.  From facility tours and peer networking to fire dancers and tiki drinks, it’s sure to be a memorable time!Guests will kick- off the event at our local, state-of-the-art biologics development

Unlocking success in the evolving pharma landscape: Insights from Norstella’s Daniel Chancellor

May 3, 2024
Norstella’s Daniel Chancellor opines on the essential big picture dynamics in today’s pharma landscape. With clinical advances benefitting patients that had been previously overlooked, pharma companies are shifting how they build their pipelines and communicate value to payers. Deciding on the right strategies relies on having access to the best data, learning the lessons from […]